Joyce Lee, MD, MS, and Erin M. Wilfong, MD, PhD provide an overview of interstitial lung disease (ILD) and some of the diseases that can lead to ILD. ILD is the umbrella term used for a large group of diseases characterized by inflammation and/or scarring in the lungs. Patients with some diseases, such as rheumatoid arthritis, scleroderma, myositis, including dermatomyositis and polymyositis (DM and PM), sarcoidosis and Sjögren's syndrome, are at higher risk for ILD. Join us to learn more about how interstitial lung disease (ILD) is diagnosed and treated.
Joyce Lee, MD, MS
PFF Senior Medical Advisor
Research and Healthcare Quality
Erin M. Wilfong, MD, PhD
Instructor of Medicine
Rheumatology & Pulmonary/Critical Care
Vanderbilt University Medical Center
Developed in collaboration with Boehringer Ingelheim Pharmaceuticals, Inc.